Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Haley

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Medical Economics|August 6, 2015
The future of interoperabilityKen Terry, Doug Fridsma, Dan Haley, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion proteinDominik Rüttinger, Rui Li, Christian H Poehlein, et al.
European Journal of Immunology|February 27, 2010
CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted miceLi-Xin Wang, Yuhuan Li, Guojun Yang, et al.
Journal of Translational Medicine|June 15, 2006
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor modelHong He, Preya Wisner, Guojun Yang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Medical Economics|August 6, 2015
The future of interoperabilityKen Terry, Doug Fridsma, Dan Haley, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion proteinDominik Rüttinger, Rui Li, Christian H Poehlein, et al.
European Journal of Immunology|February 27, 2010
CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted miceLi-Xin Wang, Yuhuan Li, Guojun Yang, et al.
Journal of Translational Medicine|June 15, 2006
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor modelHong He, Preya Wisner, Guojun Yang, et al.
Pageof 1